Series E funding round for Apellis Pharmaceuticals raising $60M in August 2017
Series E funding round for Apellis Pharmaceuticals raising $60M in August 2017
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$140.1M
Top Valuation
-
Apellis Pharmaceuticals raised $60M in a Series E round.
The round was announced on 08/01/17.
The round was led by Maha Katabi, PhD, CFA.